Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 16;11(1):5821.
doi: 10.1038/s41467-020-19507-0.

Turning genes into medicines-what have we learned from gene therapy drug development in the past decade?

Affiliations

Turning genes into medicines-what have we learned from gene therapy drug development in the past decade?

Katherine A High. Nat Commun. .

Abstract

Gene and cell therapy products approved over the past decade in Europe and North America have provided new therapeutic options for single gene disorders and for hematologic malignancies. Lessons learned, and limitations identified, are reviewed.

PubMed Disclaimer

Conflict of interest statement

The author declares the following competing interests: Formerly employed by and held equity in Spark Therapeutics (2014–2020); member of the Board of Directors, CRISPR Therapeutics (2019–present).

Figures

Fig. 1
Fig. 1. Investigational new drug applications (INDs) in gene therapy by year to US FDA.
CY calendar year. Reprinted with permission from Dr. Raj Puri.

References

    1. Russell S, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in subjects with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open label phase 3 trial. Lancet. 2017;390:849–860. doi: 10.1016/S0140-6736(17)31868-8. - DOI - PMC - PubMed
    1. Mendell, J. R. et al. Single dose gene replacement therapy for spinal muscular atrophy. N. Engl. J. Med.377, 1713–1722 (2017). - PubMed
    1. Chung DC, et al. A novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clin. Exp. Ophthalmol. 2018;46:247–259. doi: 10.1111/ceo.13022. - DOI - PMC - PubMed
    1. Mingozzi F, High KA. Overcoming the host immune response to AAV gene delivery vectors: the race between clearance, tolerance, neutralization, and escape. Annual Rev. Virol. 2017;4:511–534. doi: 10.1146/annurev-virology-101416-041936. - DOI - PubMed
    1. Boyce N. Trial halted after gene shows up in semen. Nature. 2001;414:677. doi: 10.1038/414677a. - DOI - PubMed

MeSH terms